» Articles » PMID: 8246705

Markov Models in Medical Decision Making: a Practical Guide

Overview
Publisher Sage Publications
Date 1993 Oct 1
PMID 8246705
Citations 594
Authors
Affiliations
Soon will be listed here.
Abstract

Markov models are useful when a decision problem involves risk that is continuous over time, when the timing of events is important, and when important events may happen more than once. Representing such clinical settings with conventional decision trees is difficult and may require unrealistic simplifying assumptions. Markov models assume that a patient is always in one of a finite number of discrete health states, called Markov states. All events are represented as transitions from one state to another. A Markov model may be evaluated by matrix algebra, as a cohort simulation, or as a Monte Carlo simulation. A newer representation of Markov models, the Markov-cycle tree, uses a tree representation of clinical events and may be evaluated either as a cohort simulation or as a Monte Carlo simulation. The ability of the Markov model to represent repetitive events and the time dependence of both probabilities and utilities allows for more accurate representation of clinical settings that involve these issues.

Citing Articles

Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing-remitting multiple sclerosis: a systematic review.

Lazzaro C, Bergamaschi R, Zaffaroni M, Totaro R, Paolicelli D Health Econ Rev. 2025; 15(1):3.

PMID: 39836321 PMC: 11748521. DOI: 10.1186/s13561-024-00562-y.


Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.

Dias J, Tharmanathan P, Arundel C, Welch C, Wu Q, Leighton P Health Technol Assess. 2024; 28(78):1-262.

PMID: 39644138 PMC: 11647555. DOI: 10.3310/KGXD8528.


Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer.

Lazzaro C J Egypt Public Health Assoc. 2024; 99(1):30.

PMID: 39617863 PMC: 11609134. DOI: 10.1186/s42506-024-00179-3.


Cost-effectiveness analysis of mHealth applications for depression in Germany using a Markov cohort simulation.

Freitag B, Uncovska M, Meister S, Prinz C, Fehring L NPJ Digit Med. 2024; 7(1):321.

PMID: 39551808 PMC: 11570631. DOI: 10.1038/s41746-024-01324-0.


Tailored recruitment interventions to improve bowel cancer screening in Arabic and Mandarin speaking groups: Modelled cost-effectiveness.

Lal A, Mohebi M, Wyatt K, Ghosh A, Broun K, Gao L PLoS One. 2024; 19(11):e0313058.

PMID: 39541269 PMC: 11563420. DOI: 10.1371/journal.pone.0313058.